Bank of America Corp. set a $1.80 target price on Genesis Healthcare Inc. (NYSE:GEN) in a research note released on Monday morning. The brokerage currently has a a sell rating on the stock.

Genesis Healthcare (NYSE:GEN) opened at 2.87 on Monday. The firm has a 50-day moving average of $2.36 and a 200 day moving average of $2.17. The company’s market capitalization is $258.27 million. Genesis Healthcare has a 12-month low of $1.38 and a 12-month high of $6.89.

Genesis Healthcare (NYSE:GEN) last posted its quarterly earnings results on Thursday, August 4th. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of $0.01 by $0.27. Genesis Healthcare had a negative net margin of 6.25% and a negative return on equity of 5.36%. The company earned $1.44 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same period last year, the firm posted $0.14 earnings per share. The company’s revenue for the quarter was up 1.3% on a year-over-year basis. Analysts forecast that Genesis Healthcare will post ($1.49) EPS for the current fiscal year.

Large investors have recently bought and sold shares of the stock. Geode Capital Management LLC increased its stake in Genesis Healthcare by 1.9% in the first quarter. Geode Capital Management LLC now owns 171,157 shares of the company’s stock valued at $397,000 after buying an additional 3,206 shares during the period. Alliancebernstein L.P. increased its stake in Genesis Healthcare by 5.8% in the second quarter. Alliancebernstein L.P. now owns 77,126 shares of the company’s stock valued at $137,000 after buying an additional 4,200 shares during the last quarter. Vanguard Group Inc. increased its stake in Genesis Healthcare by 0.9% in the second quarter. Vanguard Group Inc. now owns 864,806 shares of the company’s stock valued at $1,531,000 after buying an additional 7,773 shares during the last quarter. State Street Corp increased its stake in Genesis Healthcare by 2.4% in the first quarter. State Street Corp now owns 404,882 shares of the company’s stock valued at $936,000 after buying an additional 9,369 shares during the last quarter. Finally, Panagora Asset Management Inc. increased its stake in Genesis Healthcare by 4.4% in the first quarter. Panagora Asset Management Inc. now owns 236,320 shares of the company’s stock valued at $548,000 after buying an additional 9,936 shares during the last quarter. 8.07% of the stock is owned by hedge funds and other institutional investors.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.

5 Day Chart for NYSE:GEN

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.